Postoperative Pain Therapeutics Market to Witness Robust Expansion by 2029

Postoperative Pain Therapeutics Market is anticipated to grow at a significant CAGR during the forecast period. The increased demand for pain control drugs and devices is fueling the growth of the global postoperative pain therapeutics market. The number of surgeries for cancer patients is increasing all across the globe, therefore leading the market growth. One of the most adverse effects of postoperative results is the pain that causes physical distress, prolonged hospital stay, and increasing incidences of readmissions of patients post-surgery. For postoperative pain, single analgesics are not effective in providing active pain relief for moderate or severe pain and are also associated with side effects such as vomiting, nausea, bleeding, or sedation.

As far as the major focus of postoperative pain treatment is concerned, they not only reduce pain intensity, however, also improve postoperative results and increase patient comfort. Postoperative pain management is the most pivotal factor of patient treatment as it aims at initiating mobilization, enhancing patient comfort, and reducing the likelihood of cardiac, pulmonary, and neuropathic pain complications reduced the risk of thrombosis and further lessening the cost of care. The postoperative pain treatment consists mainly of multimodal analgesic treatment that includes a combination of various analgesics that act by the various mechanism of action.

Some key players operating in the market include Mallinckrodt Pharmaceuticals, Trevena, Inc., Heron Therapeutics, Pacira BioSciences, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., among others. These players are aiming at strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on.

To Request a Sample of our Report on Postoperative Pain Therapeutics Market: https://www.omrglobal.com/request-sample/postoperative-pain-therapeutics-market

Market Coverage

· The market number available for - 2022-2030

· Base year- 2022

· Forecast period- 2022-2030

· Segment Covered

· Regions Covered- Globally

· Competitive Landscape: Mallinckrodt Pharmaceuticals, Trevena, Inc., Heron Therapeutics, Pacira BioSciences, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., among others

Postoperative Pain Therapeutics Market by Segment

By Drug Class

• Opioids

• NSAIDs

• Local Anesthetics

• Tricyclic Antidepressants

• Antiepileptic Drugs

• Others

By Route Of Administration

• Oral

• Intramuscular

• Intravenous

• Others

By Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

• Others

A full Report of Postoperative Pain Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/postoperative-pain-therapeutics-market

Postoperative Pain Therapeutics Market by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.